No. 0910-0847
Expiration Date: 11/30/2020
Paperwork Reduction Act Statement
Public reporting burden for this collection of information is estimated to be 10 minutes, including time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspects of this collection of information, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Your participation/nonparticipation is completely voluntary, and your responses will not have an effect on your eligibility for receipt of any FDA services. In instances where respondent identity is needed (e.g., for follow-up of non-responders), this information collection fully complies with all aspects of the Privacy Act and data will be kept private to the fullest extent allowed by law.
WebMD Survey, HCP Drug Quality (FINAL)
Objectives and design
Note: This information is for reviewers and is not seen by respondents.
Objective: Measure physicians’ understanding of and attitudes toward drug product quality for both prescription and OTC drugs.
Medium of data collection: 10-minute online questionnaire. Physicians will be recruited from Medscape physician members.
Quota:
400 PCPs
250 specialists (50 each: cardiologists, orthopedics, rheumatologists, dermatologists, diabetologists/endocrinologists)
Screening questions
What is your clinical title?
Physician
Nurse TERMINATE
Physician assistant TERMINATE
Other healthcare practitioner TERMINATE
Not a healthcare practitioner TERMINATE
What is your specialty? (Select one.)
Cardiology “SPECIALIST”
Dermatology “SPECIALIST”
Diabetes/Endocrinology “SPECIALIST”
Family Medicine “PCP”
Internal Medicine “PCP”
Orthopedics “SPECIALIST”
Rheumatology “SPECIALIST”
Other TERMINATE
How many years have you been in practice since your residency? (If less than one year enter 0.)
_____ years in practice since residency TERMINATE IF <5; RANGE = 0-100
What percentage of your time is devoted to direct patient care? (Please do not include research, administration, or other direct responsibilities.)
___% of time devoted solely to direct patient care TERMINATE IF <40%
What is your age?
____ age in years RANGE 1-100; TERMINATE IF <26
In a typical month, how many patients do you personally treat?
_____ TERMINATE < 20
SET UP AS QUOTA QUESTION
Rx Drug Prescriptions
In the past 30 days, to approximately what percentage of your total patients did you write prescriptions?
___% of total patients I wrote prescriptions for in the past 30 days RANGE 1-100; TERMINATE IF 0
1a. Approximately what percentage of total prescriptions written in the past 30 days were for brand-name drugs vs generic drugs?
____% brand-name Rx RANGE 1-100
____% generic Rx RANGE 1-100
MUST ADD TO 100
SET UP AS QUOTA QUESTION
OTC Drug Recommendations
In the past 30 days, to approximately what percentage of your total patients did you recommend/prescribe any over-the-counter medication or treatment?
___% of total patients I recommended/prescribed any over-the-counter medications or treatments in the past 30 days RANGE 1-100; TERMINATE IF 0
2a. Approximately what percentage of total over-the-counter medications or treatments recommended/prescribed in the past 30 days were for a brand-name vs generic?
____% brand-name OTC medication/treatment RANGE 1-100
____% generic OTC medication/treatment RANGE 1-100
MUST ADD TO 100
Main questionnaire
RANDOMIZE ORDER OF QUESTIONS 3/4
Overall Quality of Drugs
IF Q1A BRAND-NAME > 0%
In your opinion, the overall quality of prescription brand-name drugs you prescribe to your patients is…
Excellent
Very Good
Good
Fair
Poor
IF Q1A GENERIC > 0%
In your opinion, the overall quality of prescription generic drugs you prescribe to your patients is…
Excellent
Very Good
Good
Fair
Poor
Prescription generic vs. prescription brand-name
To what extent do you agree or disagree with the following statements about prescription generic drugs?
RANDOMIZE
|
Strongly Agree |
Somewhat Agree |
Neither Agree Nor Disagree |
Somewhat Disagree |
Strongly Disagree |
|
5 |
4 |
3 |
2 |
1 |
1. Compared to prescription brand-name drugs, prescription generic versions are just as safe |
|
|
|
|
|
2. Compared to prescription brand-name drugs, prescription generic versions are equal in purity |
|
|
|
|
|
3. Compared to prescription brand-name drugs, prescription generic versions are just as effective |
|
|
|
|
|
4. Compared to prescription brand-name drugs, prescription generic versions are of equal quality |
|
|
|
|
|
5a. How often do you write Dispense as Written (DAW) for prescription brand-name drugs when a prescription generic drug is available?
Always
Often
Sometimes
Rarely
Never
IF 5A = A, B, OR C
5b. What are the primary reasons why you write “DAW” for prescription brand-name drugs when a prescription generic is available? (Select all that apply.)
RANDOMIZE
Patients specifically request prescription brand-name drugs
I do not trust prescription generic drugs
Generic drugs may interact with other drugs a patient is taking
I am not always aware of what generic versions are available
I do it out of habit
Other ANCHOR
IF 5A = D OR E
5c. What are the primary reasons why you do not write “DAW” for prescription brand-name drugs when a prescription generic is available? (Select all that apply.)
RANDOMIZE
Patients specifically request prescription generic drugs
It’s cheaper for my patients
Prescription generic drugs provide the same clinical benefits as their brand-name versions
I trust prescription generic drugs because they are developed under the same FDA standards as brand-name drugs
Other ANCHOR
RANDOMIZE ORDER OF QUESTIONS 6/7
IF Q2A BRAND-NAME > 0%
In your opinion, the overall quality of over-the-counter brand-name medications/treatments you have recommended to your patients is…
Excellent
Very Good
Good
Fair
Poor
IF Q2A GENERIC > 0%
In your opinion, the overall quality of over-the-counter generic/store brand medications/treatments you have recommended to your patients is…
Excellent
Very Good
Good
Fair
Poor
OTC generic vs. OTC brand-name
To what extent do you agree or disagree with the following statements about over-the-counter generic/store-brand medications/treatments?
RANDOMIZE
|
Strongly Agree |
Somewhat Agree |
Neither Agree Nor Disagree |
Somewhat Disagree |
Strongly Disagree |
|
5 |
4 |
3 |
2 |
1 |
1. Compared to brand-name medications, over-the-counter generic/store-brand versions are just as safe |
|
|
|
|
|
2. Compared to brand-name medications, over-the-counter generic/store-brand versions are equal in purity |
|
|
|
|
|
3. Compared to brand-name medications, over-the-counter generic/store-brand versions are just as effective |
|
|
|
|
|
4. Compared to brand-name medications, over-the-counter generic/store-brand versions are of equal quality |
|
|
|
|
|
Factors indicative of quality
To what extent do you agree or disagree that each item below is an indicator of drug quality?
RANDOMIZE |
Strongly Agree |
Somewhat Agree |
Neither Agree Nor Disagree |
Somewhat Disagree |
Strongly Disagree |
|
5 |
4 |
3 |
2 |
1 |
1. Drug's beneficial effect |
|
|
|
|
|
2. Recommended or prescribed by other health care practitioners |
|
|
|
|
|
3. Drug's safety profile |
|
|
|
|
|
4. Brand-name drug |
|
|
|
|
|
5. Approved for sale in the U.S. |
|
|
|
|
|
6. Made by a pharmaceutical company I trust |
|
|
|
|
|
7. Higher in cost |
|
|
|
|
|
8. Have seen or heard an advertisement for the drug |
|
|
|
|
|
Physical indicators of drug quality
Which of the following are indicators of drug quality? (Select all that apply.)
RANDOMIZE
The color, shape, or other similar characteristics of a drug
Taste
Whether pills/tablets crumble or break easily
Powdery feeling pills/tablets
Appropriate packaging (apart from pharmacist packaging)
Whether a liquid or cream appears to have separated
Whether particles are present in a bottle of liquid
Other ANCHOR
Not sure EXCLUSIVE ANCHOR
PROGRAMMER—NO BACK BUTTON ON THIS QUESTION
Aided Awareness—FDA
Which, if any, of the following are functions of the FDA in terms of regulating drug quality? (Select all that apply.)
RANDOMIZE
Oversee the research, development, manufacture, and marketing of drugs in the U.S.
Evaluate and approve new drugs before they can be sold
Make certain that all drugs marketed in the U.S.—brand and generic, prescription and over-the-counter—are safe and effective and that their health benefits outweigh known risks
Monitor truth in advertising for prescription drugs
Monitor the use of marketed drugs for unexpected health risks
Remove a drug from market if unexpected risks are detected after a drug is already approved
Manufacture drugs
Set prices for drugs
Prevent unapproved drugs from being imported to the U.S.
Test drugs
Work with other organizations, such as the United States Pharmacopeia (USP), to set quality standards for drugs
None of the above EXCLUSIVE ANCHOR
Not sure EXCLUSIVE ANCHOR
Quality of drugs imported to US
Do you believe drugs manufactured outside the U.S. and sold in the U.S. adhere to strict manufacturing standards and regulations required by the FDA?
Yes
No
Not sure
Quality of drugs manufactured outside of US
Compared to drugs manufactured within the U.S., do you think those manufactured outside the U.S. for sale inside the U.S. are…?
Much higher quality
Higher quality
About the same quality
Lower quality
Much lower quality
Not sure
IF Q13 = D OR E
Quality of drugs manufactured outside the US
Why do you believe that drugs manufactured outside the U.S. for sale inside the U.S. are of poor quality or poorer quality than drugs manufactured in the U.S.? (Select all that apply.)
RANDOMIZE
Drugs manufactured outside the U.S….
…are not strong enough
…cause more side effects
…are not as pure or could be contaminated
…use inferior active ingredients
…crumble, break, or chip more easily
…have an inferior appearance (shape, color, etc.)
…have a bad reputation
…may be from places that experience health and sanitation problems
Other (please specify: ________) ANCHOR AT BOTTOM DON'T FORCE ANSWER; IF LEFT BLANK CODE AS "Other"
None of the above EXCLUSIVE ANCHOR
Not sure EXCLUSIVE ANCHOR
Drug Shortage
Are drugs that are sold in the U.S. ever in short supply?
Yes
No
Not sure
Drug Shortage
Have your patients experienced any difficulty in filling prescription(s) due to drug shortage (not just a brief pharmacy delay for reordering)?
Yes
No
Not sure
Reasons for shortage
What are possible reasons for drug shortages? (Select all that apply.)
RANDOMIZE
Aging manufacturing facilities or manufacturing equipment
Quality/manufacturing problems (e.g., failure to produce the correct strength)
Production delays at the manufacturer
Safety problems (e.g., contamination/lack of purity)
Delays companies have experienced receiving raw materials and components from suppliers
Natural disaster (hurricane, earthquake, etc.)
Discontinuation of drug by manufacturer
FDA preventing sale of the drug from one or more manufacturers until required quality levels are met
Not sure ANCHOR EXCLUSIVE
None of the above ANCHOR EXCLUSIVE
EACH RESPONDENT RECEIVES Q18 OR Q18A. RANDOMIZE SELECTION.
ALLOW QUESTION TO BE SKIPPED IF RESPONDENT DOES NOT WANT TO ANSWER.
Impact of shortage on quality of drug
18. There are times when the FDA may take steps to maintain safety and quality standards for a drug, which can cause a supply shortage. This may be viewed as a tradeoff between constant availability of drugs on one side and quality and safety of drugs on the other. Please use the scale below to indicate where you feel that the FDA should stand on this tradeoff. The scale ranges from zero on one end, which indicates "constant availability" and ten on the other end, which indicates "quality and safety." You can choose any number on the scale to represent your opinion.
Constant Quality
Availability 0 1 2 3 4 5 6 7 8 9 10 and Safety
18a. There are times when the FDA may take steps to maintain safety and quality standards for a drug, which can cause a supply shortage. This may be viewed as a tradeoff between quality and safety of drugs on one side and constant availability on the other. Please use the scale below to indicate where you feel that the FDA should stand on this tradeoff. The scale ranges from zero on one end, which indicates "quality and safety" and ten on the other end, which indicates "constant availability." You can choose any number on the scale to represent your opinion.
Quality Constant
And Safety 0 1 2 3 4 5 6 7 8 9 10 Availability
[Display each version as shown but record data to be identical across both versions: Constant Availability should always be stored as 0 and Quality and Safety should always be stored as 10]
Products regulated by the FDA
19. Other than prescription and over-the-counter drugs, what else does the FDA regulate? (Select all that apply.)
RANDOMIZE
Medical devices
Electronic products that give off radiation (e.g., microwave ovens, sunlamps)
Cosmetics
Moisturizers
Perfumes
Bottled water
Infant formula
Other food products such as some meat and poultry
Pet foods
Tobacco products including cigarettes, smokeless tobacco, etc.
Vaccines
Vitamins and supplements
None of the above ANCHOR EXCLUSIVE
All of the above ANCHOR EXCLUSIVE
Not sure ANCHOR EXCLUSIVE
Classification
These last few questions are for classification purposes.
20.
What is your gender?
Female
Male
21. Which best describes your current work situation?
Self-employed/partner
Employee
Independent contractor
Other
22. Which one of the following best describes your current primary practice setting?
Owner (solo or group practice)
Group practice owned by a hospital
Hospital
Healthcare organization
Outpatient clinic
Academic (non-hospital), research, military, government
Other
23. In what state or U.S. territory do you practice? Select one from the dropdown menu
PROVIDE DROP-DOWN MENU WITH THE 50 STATES, DISTRICT OF COLUMBIA, PUERTO RICO, AND “OTHER U.S. COMMONWEATLH, TERRITORY, OR PROTECTORATE”
program into region variables below
Northeast (ME, NH, VT, MA, CT, RI)
Mid-Atlantic (WV, VA, DE, MD, DC, NC, PA, NJ, NY)
Great Lakes (OH, MI, IN, IL, WI, MN)
Southeast (SC, GA, FL, AL, MS, LA, TN, KY)
South Central (TX, OK, AR)
Southwest (AZ, UT, CO, NM, NV)
North Central (IA, MO, KS, NE, SD, ND)
Northwest (MT, WY, ID, OR, WA)
West (CA, AK, HI)
U.S. commonwealth, territory, or protectorate
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Rogers, Marc |
File Modified | 0000-00-00 |
File Created | 2021-01-20 |